Case report: Successful riluzole augmentation therapy in treatment-resistant bipolar depression following the development of rash with lamotrigine

Psychopharmacology

Volumn 173, Issue 1, 2004, Pages 227-228

  Singh, Jaskaran ^a   Zarate, Carlos A ^a   Krystal, Andrew D ^b  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; AMPHETAMINE; CITALOPRAM; DOXEPIN; FLUOXETINE; LAMOTRIGINE; LITHIUM; MIRTAZAPINE; NEFAZODONE; NORTRIPTYLINE; OLANZAPINE; RILUZOLE; SERTRALINE; VALPROIC ACID; VENLAFAXINE;

ADULT; ANAMNESIS; BIPOLAR DEPRESSION; CASE REPORT; CLINICAL FEATURE; DRUG MECHANISM; DRUG MEGADOSE; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; ERYTHEMA; FEVER; HUMAN; LABORATORY TEST; LETTER; MALE; PAPULAR SKIN DISEASE; PRIORITY JOURNAL; PRURITUS; SIDE EFFECT;

ADULT; ANTIDEPRESSIVE AGENTS; BIPOLAR DISORDER; DRUG SYNERGISM; EXANTHEMA; EXCITATORY AMINO ACID ANTAGONISTS; HUMANS; MALE; RILUZOLE; TREATMENT OUTCOME; TRIAZINES;

EID: 2342580069     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-003-1756-8     Document Type: Letter

References (9)

1. Calabrese JR, Bowden CL, Sachs GS et al. (1999) A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J Clin Psychiatry 60:79-88
2. Calabrese IR, Sullivan JR, Bowden CL et al. (2002) Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and management. J Clin Psychiatry 63:1012-1019
3. Ghaemi SN, Hsu DJ, Soldani F et al. (2003) Antidepressants in bipolar disorder: the case for caution. Bipolar Disord 5:421-433
4. Goodwin GM (2003) Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 17:149-173; discussion 147
5. Goodwin, FK, Jamison KR (1990) Manic-depressive Illness. Oxford University Press, New York
6. Keck I, Paul E, Nelson EB, McElroy SL (2003) Advances in the pharmacologic treatment of bipolar depression. Biol Psychiatry 53:671-679
7. Prakriya M, Mennerick S (2000) Selective depression of low-release probability excitatory synapses by sodium channel blockers. Neuron 26:671-682
8. Simpson SG, Jamison KR (1999) The risk of suicide in patients with bipolar disorders. J Clin Psychiatry 60 (Suppl 2):53-56; discussion 75-76, 113-116
9. Zarate CA Jr, Payne JL, Quiroz JA, Sporn J, Denicoff KD, Luckenbaugh D, Charney DS, Manji HK (2004) An open-label trial of riluzole in treatment-resistant major depression. Am J Psychiatry 161:171-174